An intuitive Bayesian spatial model for disease mapping that accounts for scaling
Andrea Riebler, Sigrunn H. S{\o}rbye, Daniel Simpson, H{\aa}vard, Rue

TL;DR
This paper introduces a new Bayesian spatial model for disease mapping that improves parameter interpretability and transferability across different spatial structures, addressing limitations of existing models like BYM.
Contribution
The paper proposes a scaled, reparameterized Bayesian spatial model that allows independent hyperparameter control and enhances interpretability in disease mapping.
Findings
The new model performs well in simulation studies.
It offers better hyperparameter interpretability.
It matches existing models in predictive performance.
Abstract
In recent years, disease mapping studies have become a routine application within geographical epidemiology and are typically analysed within a Bayesian hierarchical model formulation. A variety of model formulations for the latent level have been proposed but all come with inherent issues. In the classical BYM model, the spatially structured component cannot be seen independently from the unstructured component. This makes prior definitions for the hyperparameters of the two random effects challenging. There are alternative model formulations that address this confounding, however, the issue on how to choose interpretable hyperpriors is still unsolved. Here, we discuss a recently proposed parameterisation of the BYM model that leads to improved parameter control as the hyperparameters can be seen independently from each other. Furthermore, the need for a scaled spatial component is…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
